Navigation Links
QualityMetric Appoints Chief Innovation and Research Officer
Date:1/29/2008

James E. Dewey, PhD, QualityMetric co-founder and board member, health risk appraisal (HRA) pioneer, and successful entrepreneur rejoins the company.

LINCOLN, R.I., Jan. 29 /PRNewswire/ -- QualityMetric today announced the return of James E. Dewey, PhD to the company he helped found in 1997. Dewey, whose new title is Chief Innovation and Research Officer (CIRO), reports directly to John E. Ware, PhD, QualityMetric's Chief Executive Officer and co- founder.

"As CIRO, Jim will lead QualityMetric's team of scientists and direct our product development efforts," says Ware. "We are experiencing an unprecedented level of interest in measuring outcomes from all corners of the healthcare landscape. This heightened demand requires creativity and inspired innovation from our team, and Jim is the person to provide this spark."

According to Dewey, "QualityMetric is an exciting place to be right now. We have assembled an amazing team of talented people including measurement scientists, data analysts, and IT professionals. I look forward to channeling this talent and energy to deliver patient-centered, outcomes-based systems to improve healthcare."

Dewey received his doctorate from Purdue University, conducting landmark research validating the Centers for Disease Control Health Risk Appraisal. While completing his degree, he founded and ran one of the country's first hospital-based Wellness Centers. Dewey's first company, Healthtech Industries, developed custom software applications in health risk appraisal for clients like Mobil Oil Corporation, the United States Navy, and multiple state and local health departments.

Recognizing that many doctors, nurses, and educators found risk appraisal systems complex and frustrating, he formed his second company, Response Technologies, Inc, developing the world's first fully integrated and self-contained system for conducting point-of-care health and health risk assessments.

Dewey and Ware co-fo
'/>"/>

SOURCE QualityMetric
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Allos Therapeutics Appoints Bruce K. Bennett as Vice President, Manufacturing
2. Murad, Inc. Appoints Jeff Murad to Vice-President of Product Development
3. ZYTO Corp. Appoints New Chief Operations Officer and New Chief Financial Officer
4. Batesville Holdings, Inc., Appoints Cynthia L. Lucchese Senior Vice President and Chief Financial Officer
5. VNUS Medical Technologies Appoints Peter Osborne as Chief Financial Officer
6. LifeSync Corporation Appoints Nancy McLane as Senior Vice President Operations
7. ChemoCentryx Appoints Edward E. Penhoet, Ph.D., to Board of Directors
8. Cardiva Medical, Inc. Appoints Two New Officers: Malcolm Farnsworth as Vice President of Finance and Chief Financial Officer and Tara Zerby as Vice President of Business Development and Marketing
9. Kendle Appoints Industry Veteran to Lead Asia/Pacific Expansion
10. LifeVantage Corporation Appoints Industry Veteran David Brown as President & CEO
11. Crdentia Appoints Debbie Griffith to Director of Business Development, Reporting Directly to CEO
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/17/2014)... identified new pain relief targets that could be ... researchers at King,s College London made the discovery ... the periphery of the body. , Dr Marzia ... mechanisms underlying pain generation and our findings could ... effects." , One potential side effect of some ...
(Date:4/17/2014)... Two recent papers by a University of ... help scientists develop treatments or vaccines for Dengue ... and other disease-causing flaviviruses. , Jeffrey S. Kieft, ... at the School of Medicine and an early ... and colleagues recently published articles in the scholarly ...
(Date:4/17/2014)... MAYWOOD, Il. (April 17, 2014) Doctors who ... disease called lymphangioleiomyomatosis (LAM) can face an agonizing ... progression of the disease and help relieve shortness ... lung transplants, and sirolimus can cause potentially fatal ... said pulmonologist Dr. Daniel Dilling, medical director of ...
(Date:4/17/2014)... (BUSM) have discovered that the anti-seizure drug ezogabine, ... findings, reported in the American Journal of ... more effective treatments for alcoholism. , Excessive consumption ... of illness and death in the U.S. and ... productivity of workers and necessitating huge health care ...
(Date:4/17/2014)... scientists and their partners have found that their proprietary ... transmission of multiple sexually transmitted infections (STIs) in both ... virus 2 (HSV-2), and human papillomavirus (HPV). The USAID-funded ... is effective against multiple strains of HIV, and has ... three viruses of at least eight hours prior to ...
Breaking Medicine News(10 mins):Health News:New pain relief targets discovered 2Health News:CU researchers discover target for treating dengue fever 2Health News:Patients with rare lung disease face agonizing treatment dilemma 2Health News:Patients with rare lung disease face agonizing treatment dilemma 3Health News:BUSM researchers find anti-seizure drug may reduce alcohol consumption 2Health News:Animal study provides first evidence that gel can prevent multiple virus transmission in vagina/rectum 2
... Programming Announced in Lead Up to World AIDS Day (Dec. ... PARK, Calif., Nov. 26 For more than ten years, ... the U.S. and abroad to reach the public with information ... surrounding the disease. The Foundation,s media partnerships leverage significant ...
... 26, 2008 The American Society for Gastrointestinal ... in U.S. cancer deaths and incidence rates, with colorectal ... ASGE, representing the specialists in colorectal cancer screening, is ... among men and women dropped 4.3 percent per year ...
... of Matthew L. Myers President, Campaign for Tobacco-Free Kids ... 26 Guatemala,s Congress on November 24, 2008, approved ... places, including restaurants and bars, be 100 percent smoke-free. ... protecting the health of Guatemala,s 13 million residents and ...
... it,s cheaper and less time-consuming than in-person visits, study ... counseling may be as effective as face-to-face counseling in ... University of Florida study included 234 obese women, ages ... Florida. , All the women completed a six-month weight-loss ...
... of our genetic material--about 2%-- performs the crucial task scientists ... serve as a blueprint for the production of proteins, the ... of human DNA is converted into intermediary molecules called RNAs, ... , And what of the other 98% of the ...
... taste sensation of rats to sweet foods and drives ... neuroscientists. Findings from the Penn State study could uncover ... reveal how flab hooks the brain on sugary food., ... you tend to consume it in higher amounts," said ...
Cached Medicine News:Health News:Kaiser Family Foundation Partners With Media Around The Globe to Address HIV/AIDS 2Health News:Kaiser Family Foundation Partners With Media Around The Globe to Address HIV/AIDS 3Health News:Kaiser Family Foundation Partners With Media Around The Globe to Address HIV/AIDS 4Health News:Kaiser Family Foundation Partners With Media Around The Globe to Address HIV/AIDS 5Health News:ASGE encouraged by drop in colorectal cancer deaths 2Health News:Guatemala's Congress Takes Action to Save Lives By Approving Strong Smoke-free Legislation 2Health News:Guatemala's Congress Takes Action to Save Lives By Approving Strong Smoke-free Legislation 3Health News:Over-the-Phone Weight Loss Counseling Works 2Health News:Scientists at CSHL uncover new RNA processing mechanism and a new class of small RNAs 2Health News:Scientists at CSHL uncover new RNA processing mechanism and a new class of small RNAs 3Health News:Route to obesity passes through tongue 2Health News:Route to obesity passes through tongue 3
(Date:1/15/2014)... Quebec , Jan. 15, 2014  Valeant Pharmaceuticals International, ... announced that the applicable waiting period under the Hart-Scott-Rodino ... the previously announced tender offer by its indirect wholly-owned ... outstanding shares of common stock of Solta Medical, Inc. ...
(Date:1/14/2014)... FRAMINGHAM, Mass. , Jan. 14, 2014 ... a leading innovator of less invasive, miniaturized circulatory support ... failure, today announced that it expects revenues for the ... bringing expected full-year 2013 revenues to approximately $208 million. ...
(Date:1/14/2014)... HILLSBORO, Ore. , Jan. 14, 2014 /PRNewswire-iReach/ -- ... and a targeting guide with accompanying instrumentation to place ... new adjunct to the soft tissue (e.g. ligament) repair ... soft tissue repair heals. (Photo: http://photos.prnewswire.com/prnh/20140114/MN45636 ...
Breaking Medicine Technology:Valeant Pharmaceuticals Announces Receipt Of Antitrust Clearance For Its Previously Announced Acquisition Of Solta Medical, Inc. 2Valeant Pharmaceuticals Announces Receipt Of Antitrust Clearance For Its Previously Announced Acquisition Of Solta Medical, Inc. 3HeartWare International Announces Preliminary Fourth Quarter 2013 Revenues 2HeartWare International Announces Preliminary Fourth Quarter 2013 Revenues 3HeartWare International Announces Preliminary Fourth Quarter 2013 Revenues 4Acumed introduces the Scapho-Lunate Inter Carpal (SLIC) Screw System 2Acumed introduces the Scapho-Lunate Inter Carpal (SLIC) Screw System 3
... N.J. , Aug. 2 Octapharma ... from the U.S. Food and Drug Administration (FDA) ... the replacement therapy developed specifically for von Willebrand Disease (VWD). ... Products Development , which helps to advance the development of ...
... EMERYVILLE, Calif. , Aug. 2 Bionovo, ... results from studies in neurons of its drug candidate Menerba ... in the Public Library of Science (PLoS) One, describes a ... from stem cells, and express native estrogen receptors. Menerba, an ...
Cached Medicine Technology:FDA Confirms Orphan Drug Exclusivity Approval for wilate®, Octapharma USA's New Therapy for Common Inherited Bleeding Disorder 2FDA Confirms Orphan Drug Exclusivity Approval for wilate®, Octapharma USA's New Therapy for Common Inherited Bleeding Disorder 3FDA Confirms Orphan Drug Exclusivity Approval for wilate®, Octapharma USA's New Therapy for Common Inherited Bleeding Disorder 4FDA Confirms Orphan Drug Exclusivity Approval for wilate®, Octapharma USA's New Therapy for Common Inherited Bleeding Disorder 5Bionovo Announces Publication Describing Menerba's Effect on Neural Pathways Related to Temperature Regulation 2Bionovo Announces Publication Describing Menerba's Effect on Neural Pathways Related to Temperature Regulation 3Bionovo Announces Publication Describing Menerba's Effect on Neural Pathways Related to Temperature Regulation 4
ReNu 1 Step Enzymatic Cleaner with ReNu Multi-Purpose Solution removes protein deposits while lenses are being disinfected. Its a one-step process that saves time. Removes stubborn deposits from dai...
...
Wet-Field Hemostatic Eraser bipolar tip, packsize is 10/box....
... intraocular lenses. The instrument consists of a ... implant and divides the implant into two ... halves of the lens so that unwanted ... chamber is avoided. The instrument is passed ...
Medicine Products: